NEXTURNBIOSCIENCE Co., Ltd. Stock

Equities

A089140

KR7089140008

Industrial Machinery & Equipment

End-of-day quote Korea S.E. 06:00:00 2024-04-25 pm EDT 5-day change 1st Jan Change
3,515 KRW -0.71% Intraday chart for NEXTURNBIOSCIENCE Co., Ltd. -3.96% -36.32%
Sales 2022 28.99B 21.08M Sales 2023 41.26B 29.99M Capitalization 51.87B 37.71M
Net income 2022 -4.69B -3.41M Net income 2023 9.68B 7.04M EV / Sales 2022 3.91 x
Net Debt 2022 47.41B 34.47M Net Debt 2023 45.63B 33.17M EV / Sales 2023 2.36 x
P/E ratio 2022
-12.3 x
P/E ratio 2023
6.23 x
Employees 60
Yield 2022 *
-
Yield 2023
-
Free-Float 91.24%
More Fundamentals * Assessed data
Dynamic Chart
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Mirae Corporation announced that it has received KRW 2.6 billion in funding from NEXTURNBIOSCIENCE Co., Ltd., UA Co.,Ltd CI
Mirae Corporation announced that it has received KRW 10 billion in funding from NEXTURNBIOSCIENCE Co., Ltd. CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI
NexturnBioScience Plans 1 Billion Won Capital Raise through Stock Offering; Shares Jump 4% MT
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 5.9999959 billion in funding CI
NEXTURNBIOSCIENCE Co., Ltd. completed the acquisition of 10.59% stake in Mirae Corporation from KANGLIM Co., Ltd. CI
Mirae Corporation announced that it expects to receive KRW 5 billion in funding from NEXTURNBIOSCIENCE Co., Ltd., UA Co.,Ltd CI
Mirae Corporation announced that it expects to receive KRW 15 billion in funding from NEXTURNBIOSCIENCE Co., Ltd. CI
Mirae Corporation announced that it expects to receive KRW 15 billion in funding from NEXTURNBIOSCIENCE Co., Ltd. CI
NEXTURNBIOSCIENCE Co., Ltd. agreed to acquire a 10.59% stake in Mirae Corporation from KANGLIM Co., Ltd. CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
NEXTURNBIOSCIENCE Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
1 day-0.71%
1 week-3.96%
Current month-19.75%
1 month-21.19%
3 months-20.83%
6 months-26.23%
Current year-36.32%
More quotes
1 week
3 460.00
Extreme 3460
3 780.00
1 month
3 320.00
Extreme 3320
4 645.00
Current year
3 320.00
Extreme 3320
5 730.00
1 year
3 320.00
Extreme 3320
16 550.00
3 years
3 320.00
Extreme 3320
67 000.00
5 years
3 320.00
Extreme 3320
67 000.00
10 years
3 320.00
Extreme 3320
67 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 -
Comptroller/Controller/Auditor 51 -
Members of the board TitleAgeSince
Director/Board Member 51 -
Chief Executive Officer 70 -
Director/Board Member 47 -
More insiders
Date Price Change Volume
24-04-26 3,515 -0.71% 25,755
24-04-25 3,540 -1.67% 17,790
24-04-24 3,600 0.00% 26,155
24-04-23 3,600 -1.77% 27,641
24-04-22 3,665 +0.14% 29,195

End-of-day quote Korea S.E., April 25, 2024

More quotes
NexturnBioScience Co Ltd, formerly Nexturn Co Ltd, is a Korea-based company principally engaged in the manufacture and sale of computer numerical control (CNC) automatic lathes. The Company's products are used for automobile parts such as engine parts, steering devices, wipers and others, marine engine parts, medical devices and implants, communication equipment such as mobile phones, digital multimedia broadcasting (DMB) devices and others, electronic components such as liquid crystal display (LCD), copier, printer and others, hydraulic and pneumatic parts, among others. It also provides related parts, after-sales service.
More about the company
  1. Stock Market
  2. Equities
  3. A089140 Stock